Immunetrics is a disease modeling company with a unique solution to sepsis, a runaway inflammatory response that claims more victims in the U.S. each year than breast, colon, and prostate cancer combined. Immunetrics possesses the first known comprehensive model of the inflammatory response. With this model, Immunetrics can help drug companies develop new therapies for sepsis and can help hospitals manage this complex syndrome. The model can also be extended to other conditions, including transplant rejection and restenosis
